Woodline Partners LP Rocket Pharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 652,865 shares of RCKT stock, worth $1.62 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
652,865
Previous 652,421
0.07%
Holding current value
$1.62 Million
Previous $8.2 Million
46.9%
% of portfolio
0.03%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$43.9 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$31.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$16.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$15.4 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$12.9 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $188M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...